Earnings ·
Envista reports Q3 adjusted EPS of $0.40, raises full-year guidance to $1.54-$1.58
NVSTEnvista Holdings Corp
Envista Holdings reported third-quarter sales of $691 million and adjusted diluted earnings per share of $0.40, up 25% year-over-year. The company raised its full-year 2026 adjusted EPS guidance to a range of $1.54 to $1.58 from the previous estimate of $1.50 to $1.55. GAAP net income was $508 million, significantly boosted by a $428 million non-cash foreign currency translation gain related to legal entity simplification. The company also repurchased approximately $10 million in shares during the quarter and reported adjusted EBITDA of $106 million. Envista operates in the dental industry, providing technologies, consumables, and services through brands such as Nobel Biocare and Kerr.